...
首页> 外文期刊>African Journal of Biotechnology >In vivo, hypolipidemic and antioxidant effects of Citrullus colocynthis pulp extract in alloxan-induced diabetic rats
【24h】

In vivo, hypolipidemic and antioxidant effects of Citrullus colocynthis pulp extract in alloxan-induced diabetic rats

机译:体内,柑橘类癌蛋白酶蛋白酶诱导糖尿病大鼠枸杞子提取物的低血散和抗氧化作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The study was designed to evaluate the effect of?Citrullus colocynthis?pulp hydro-ethanol extract on alloxan-induced hyperlipidemia in diabetic rats.?24 albino rats?with body weights of 150 to 200 g were divided into one control and three experimental groups. Group 1 was the normal control rats, orally administered physiological saline. Groups 2, 3 and 4 were diabetic rats orally administered physiological saline (diabetic, untreated), glibenclamide (diabetic, GL) or?C. colocynthis?extract (300 mg /kg) (diabetic, CC), respectively.?All treatments were administered orally, on a daily basis, for a period of 30 days. At the end of the experimental period, animals in all the four groups were fasted for 12 h and then sacrificed. Blood samples and liver tissues were taken for the determination of total cholesterol, triglycerides, free fatty acids and phospholipids. Portions of the liver were homogenized and used for determination of lipid peroxidation biomarkers [thiobarbituric acid reactive substances?(TBARS) and lipid hydroperoxides (HPx)], and for biological antioxidant levels [reduced glutathione (GSH), superoxide dismutase (SOD) and catalase (CAT)].? The results show significant decreases in the levels of total cholesterol, triglycerides, free fatty acids and phospholipids in serum and liver of?C. colocynthistreated diabetic rats when compared to diabetic untreated rats.? Also, relative to diabetic untreated rats, oral administration of?C. colocynthis?to diabetic rats significantly reduced elevated levels of liver TBARS and HPx to near normal levels and caused significant increases in GSH, SOD and CAT levels, an effect that is comparable to but more pronounced than that of glibenclamide. These results indicate that?C. colocynthis?pulp hydro-ethanol extract possesses potent hypolipidemic and antioxidant actions in alloxan induced diabetic rats.
机译:该研究旨在评估β-柑橘类Colocynthis的疗效β致毒性诱导的糖尿病大鼠的高脂质血症的效果。24醇类大鼠α24白化大鼠αα,其重量为150-200g,分为一个对照和三个实验组。第1组是正常对照大鼠,口服给药的生理盐水。组2,3和4组是口服给药的生理盐水(糖尿病,未经处理),Glibenclamide(糖尿病,GL)或βc的糖尿病大鼠。 Colocynthis(300mg / kg)(糖尿病,Cc)分别为口服,每天服用治疗30天。在实验期结束时,所有四组的动物禁食12小时,然后处死。采取血液样品和肝组织用于测定总胆固醇,甘油三酯,游离脂肪酸和磷脂。肝脏的部分均化并用于测定脂质过氧化生物标志物[硫氨基吡啶酸反应性物质吗?(TBARS)和脂质氢过氧化物(HPX)],以及用于生物抗氧化水平[降低的谷胱甘肽(GSH),超氧化物歧化酶(SOD)和过氧化酯酶(猫)]。?结果表明,血清和肝脏中总胆固醇,甘油三酯,游离脂肪酸和磷脂水平的显着降低。与糖尿病未经处理的大鼠相比,结合结肠基因糖尿病大鼠。而且,相对于糖尿病未经处理的大鼠,口服施用?C。 Colocynthis?对于糖尿病大鼠显着降低了肝脏TBAR和HPX水平的升高,并导致GSH,SOD和猫水平的显着增加,其效果与Glibenclamide的效果相当。这些结果表明?C。 Colocynthis?纸浆氢乙醇提取物在阿萨克兰诱导的糖尿病大鼠中具有有效的低血脂和抗氧化作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号